| Predicate |
Object |
| contentType |
Editorial|Comment |
| endingPage |
852 |
| issn |
0002-9343 |
| issueIdentifier |
12 |
| pageRange |
850-852 |
| publicationName |
The American Journal of Medicine |
| startingPage |
850 |
| bibliographicCitation |
Gaspoz J, de Moerloose P. Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner? The American Journal of Medicine. 2004 Jun;116(12):850–2. doi: 10.1016/j.amjmed.2004.03.008. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00aee620ef91dd64fb5e561be0466178
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09c3efcc79b70d1a982eeb70e817f093 |
| date |
2004-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/15178502
https://doi.org/10.1016/j.amjmed.2004.03.008 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0002-9343
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/431 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner? |
| discusses |
http://id.nlm.nih.gov/mesh/M0021526
http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0001864
http://id.nlm.nih.gov/mesh/M0008434
http://id.nlm.nih.gov/mesh/M0155432 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D013988Q000031
http://id.nlm.nih.gov/mesh/D002318Q000517
http://id.nlm.nih.gov/mesh/D010975Q000627
http://id.nlm.nih.gov/mesh/D001241Q000627
http://id.nlm.nih.gov/mesh/D013988Q000627
http://id.nlm.nih.gov/mesh/D005343Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000077144
http://id.nlm.nih.gov/mesh/D006801 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 |